os 8008的相關文章
os 8008的相關公司資訊
125543-144 - Meeting Library | ASCO Meeting Abstracts, Presentations, Educa
瀏覽:926
日期:2026-04-23
A randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin (GC) chemotherapy plus necitumumab (IMC-11F8/LY3012211) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq ......看更多














